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Background: The number of patients with one or more chronic diseases is rising. In several standards of care
there is a focus on enhancing self-management. We applied the concept of personalization on self-management
support and developed a self-management screening questionnaire (SeMaS). The main research objective is to
assess the effectiveness of the SeMaS questionnaire and subsequent personalized self-management on patients’
self-management behaviors.
Methods/Design: A cluster randomized controlled trial will be set up in 15 general practices in the Netherlands.
The practices are all group practices, and member of one care group. The practices will be assigned to the control or
intervention arms by stratified randomization. The strata are determined by the participation of the practice nurses in a
course for behavioral change, and the nurse’s workload. Patients can be included if they are over 18 years of age, have
at least one chronic condition and have a checkup appointment with the practice nurse in the inclusion period. The
intervention consists of screening patients with the SeMaS questionnaire, producing a graphic profile with the abilities
or barriers for self-management. Patients will receive tailored feedback. Practice nurses are trained in using the profile
to enhance self-management of the patient and provide personalized self-management support. The use of individual
care plans and self-management interventions is stimulated. In the control arm patients will receive care as usual.
Patients of both trial arms will be asked to fill in the SeMaS questionnaire and additional questionnaires at inclusion
and after 6 months. The primary outcome is the difference in the level of patient activation (PAM-13) between baseline
and 6 months. Secondary outcomes include patient measures for lifestyle factors (exercise, diet, smoking), and process
measures from medical record data analysis.
Discussion: This manuscript presents the protocol for a cluster randomized clinical trial of personalized
self-management support using the SeMaS questionnaire in chronically ill patients in primary care. By carrying
out this study, scientific evidence is built for the effectiveness of personalized self-management support.
Trial registration: The Netherlands National Trial Register: NTR3960.
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The number of patients with one or more chronic con-
ditions is vastly rising worldwide. In the United States,
133 million people suffered from one or more chronic
disease in 2005 [1]. Hoeymans et al. stated that in the
Dutch population 4.5 million people (28%) suffer from
at least one chronic disease [2]. Tacken et al. showed
that the percentage of patients who suffered from at
least one chronic disease rose from 12.6% in 2003 to
15.0% in 2009 [3]. This can be explained by ageing of
the population. The increase in number of patients with
one or more chronic diseases will increase the workload
in primary care, and increase healthcare costs. Chronically
ill patients usually have several consultations with their
general practitioner (GP) or practice nurse each year.
To increase quality of care, the quality of life of chron-
ically ill patients, and to sustain healthcare costs, there is
a large focus on enhancing self-management in people
with chronic diseases in current guidelines and standards
of care [4-6]. These guidelines are often based on the
chronic care model of Wagner et al., a framework for
integrated, patient-centered care [7]. The Department of
Health of the United Kingdom defined self-management
as ‘the care taken by individuals towards their own health
and well being: it comprises the actions they take to lead a
healthy lifestyle; to meet their social, emotional and psy-
chological needs; to care for their long-term condition;
and to prevent further illness or accidents’ [8]. Following
this definition, self-management also means that the
patient takes more responsibility for his or her own health.
Self-management programs have been developed for
various chronic diseases and lifestyle changes [9-12]. Sev-
eral studies have shown positive effects of these programs
on clinical outcome measures, as well as patient-related
outcome measures, such as participation, knowledge or
activation [13-18]. These studies identified several factors
that influence the probability of successfully completing
the intervention, such as social support or self-efficacy.
In other fields of research, especially human genetics,
the concept of personalized medicine has been introducedIntervention



















Figure 1 Logic model of the hypothesized effects of self-managemen[19]. In the field of genetics, patients are genetically
screened, and subsequently receive treatment that is
adapted to their genomic profile. In psychology, treatment
is adjusted to psychological characteristics and thus,
person-centered [20-22]. We applied the concept of per-
sonalization to self-management support. Here, personal-
ization is defined as adjusting the self-management support
to the individual characteristics of the patient. For example,
in the case of low self-efficacy, the practice nurse and
patient make an individual care plan with small steps in
goal setting to enhance the self-efficacy of the patient.
Current generic self-management measures include the
patient activation measure (PAM-13), which measures
the current level of self-management and the Health
Education Impact Questionnaire (heiQ), measuring the
outcome of an intervention or education program [23,24].
However, there was no generic instrument available to
identify factors that could hinder successful self-manage-
ment. For this purpose, we developed a self-management
screening questionnaire (SeMaS), as described below.
Providing patients with personalized self-management
support, we expect the patient-activation level to increase,
which subsequently has a positive effect on health-related
lifestyles, knowledge, skills, and the ability to take care of
the chronic condition. This in turn will positively influence
overall health and wellbeing. The SeMaS questionnaire
will provide specific information about the abilities and
possible barriers for self-management. Using a manual,
the healthcare provider will have a starting point to influ-
ence possible barriers and stimulate self-management.
This is shown in the logic model in Figure 1.
The main research objective is to assess the effectiveness
of the SeMaS questionnaire and subsequent personalized
self-management support on patients’ self-management
behaviors.
Methods/Design
We will conduct a two-arm practice-level randomized
trial with a postponed intervention in the control arm.
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the intervention was implemented at general practice level
instead of patient level. Another problem in this study
was the risk of contamination when control patients
would be exposed to elements of the intervention. There-
fore, randomizing all patients within a general practice
(representing a cluster) to either the intervention or the
control was the most logical choice.
Practices
For this study, we recruited the practices through the
primary care cooperation De Ondernemende Huisarts
(DOH), or The Innovative General Practitioner. DOH
is an innovative organization led by GPs who have a
subspecialization. The care group comprises 15 general
practices in the southeast part of the Netherlands, varying
in size and degree of urbanization. Half of the practices
are situated in the city, while the other half are located
in surrounding villages. The context of this care group
provided a well-developed infrastructure to perform this
study. Together the practices serve approximately 115,000
patients who are registered at the practice according to
the Dutch capitation system. The practices are group
practices, in which groups of GPs work together, and are
supported by practice nurses (64 GPs and 54 nurses in
total). These nurses usually perform planned checkups
following treatment protocols, while the GPs perform
the annual checkups for chronically ill patients.
DOH has formulated a policy agenda for self-manage-
ment in chronic patients [25]. The cooperation offers
several self-management interventions or types of self-
management support that are evidence-based as far as
possible. The program of interventions consists of group
courses, including the course ‘Beyond good intentions’,
and group courses for smoking cessation, and an exercise
project, KICK, which guides patients to local sport unions
via physiotherapists [18,26].
The eHealth interventions consist of the Diabetes
Interactive Education Program (DIEP), an Internet deci-
sion-aid for smoking cessation, patient education via in-
formative websites about asthma and chronic obstructive
pulmonary disease (COPD) from the Lung Foundation
Netherlands and exercise (30minutenbewegen.nl), and a
patient portal with options for self-monitoring and digital
coaching on exercise, diet and smoking cessation [27].Table 1 Randomization strata and the number of practices pe
Low participation in behavioral chang
Intervention Control
Low volume of practice nurses 2 1
High volume of practice nurses 1 3
Volume of practice nurses: the number of full time equivalents divided by the num
practice nurses who attended the training for behavioral change to enhance self-m
questionnaire.The GPs and practice nurses have had training in
motivational interviewing and the approach known as
actual practice and maintenance, consisting of a behav-
ior change model (referred to as a series of steps)
and so-called person-related factors to enhance self-
management [28,29]. Motivational interviewing is a
client-centered counseling technique to facilitate and
engage intrinsic motivation of the patients in order to
change behavior. It has been found to be effective in
several studies [30-32].
All 15 general practices of the DOH will participate in
the trial. We recruited the practices through the DOH
cooperation. The practice nurses will receive training in
working with the SeMaS. As mentioned, we will perform
randomization at the cluster level. Furthermore, as the
ability of the practice nurse to influence the self-
management behavior of the patient can affect the
study results, we dichotomized practices into two equal
groups using the percentage of practice nurses in the
practice that participated in the behavioral change
training [29]. Also, practices were dichotomized in two
equal groups using the volume of practice nurses
corrected for practice size, as the workload can affect
the study results as well. This resulted in four strata.
For each stratum, a separate two-block randomization
list was produced to randomize the practices to the
control or intervention arm [33]. Two practices were
coupled in the randomization procedure to prevent
contamination, because one practice nurse worked in
both practices. The final allocation of practices is shown
in Table 1.
A representative of the care group DOH consented
with participation in the study for all practices. After
performing the randomization procedure, we informed
the practices about participation in the study.
Patients
The population of chronically ill patients in the prac-
tices consists of approximately 9,100 patients with car-
diovascular risk, 3,900 diabetes mellitus patients,
1,500 asthma patients and 900 COPD patients. These
patients are regularly seen by the practice nurse. Pa-
tients can be included if they are over 18 years of age,
have at least one of these chronic conditions and have
a checkup appointment with the practice nurse in ther stratum of the SeMaS study




ber of patients in the practice. Participation in training: percentage of the
anagement that was provided in 2011 [29]. SeMaS, self-management screening
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information about the study and informed consent
forms to patients to participate in the study approxi-
mately 4 weeks before the planned checkup appoint-
ment of the patient. Patients will be given the option
to fill in the questionnaires either digitally through the
Internet or on paper. Participating patients will be
asked to fill in an evaluative questionnaire one week
after their consultation, and the final questionnaire after
6 months.
Medical-record data extraction will be performed by
the data management agency of the care group. They canControl arm: 8 practices













15 DOH primary care
T=1 week: Evaluation questionnaire 
for patient 
Figure 2 Flow chart of the self-management screening questionnaire
measurements at time (T) = 6 months include: SeMaS, Patient Activation M
health literacy in adults (S-TOFHLA), rapid assessment of physical activity (R
smoking. DOH, De Ondernemende Huisarts (The Innovative General Practitioprovide anonymous data on the participating patients
from the research period. The research team will perform
medical-record data analysis. The flow chart of the trial is
shown in Figure 2.
Ethical approval
The study has been reviewed by the local Medical
Research Ethics Committee, the CMO region Arnhem-
Nijmegen (registration number: 2012/561). The study will
be carried out in accordance with the applicable rules
concerning the review of research ethics committees and
informed consent.Intervention arm: 7 practices
Training SeMaS and 
practice visit
Recruitment of 50 
patients per practice
Baseline measurements
T=0: Check-up appointment with 
practice nurse with personalized 
self management support with 
possibly
- Self measurement instructions
- Referral to self management 
interventions
- Individual care plan








T=1 week: Evaluation questionnaire for 
patient 
(SeMaS) cluster randomized trial. Baseline measurements and
easure (PAM-13), perceived competence scale, short test of functional
APA), rapid eating assessment for participants-short (REAP-S), and
ner).
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The SeMaS questionnaire was developed in four steps.
First, we performed a broad, systematic literature search
to identify reported aspects that are associated with
successful or unsuccessful self-management. Second, we
held focus groups with professionals from primary care
(GPs, psychologist, dietitian, physiotherapist, pharmacist)
and patients to identify the most important aspects
that would determine the chance of successful self-
management, based on their experience and the literature
search. The final selection of aspects was made in the stake-
holders group, combining the findings of the literature
study and focus groups. The aspects were selected if
they were mentioned in the focus group, found in the
literature, and an instrument was available. Third, we de-
veloped a prototype of the SeMaS and tested it in 24 con-
sultations for applicability and readability, resulting in
minor adjustments. Fourth, we validated the SeMaS in
a test with 200 patients. Patients completed the SeMaS
before their control visit with a practice nurse. After two
months, patients completed a second questionnaire with
SeMaS, reference questionnaires, and an additional ques-
tionnaire for process evaluation. Also, medical record
data was extracted for process evaluation. Specifically,
data were collected on referrals to self-management inter-
ventions, and advice or instructions provided to en-
hance self-management. Analysis of the data resulted
in minor adjustments of the SeMaS.
SeMaS is designed to be generally applicable to patients
with chronic conditions. It consists of 27 items divided
over the relevant aspects of self-management, namely,
burden of disease, locus of control, self-efficacy, social
support, coping style, anxiety, depression and skills
(computer, groups and self-care). A publication of the
validation study of SeMaS is in progress.
Screening with SeMaS results in a personal profile on
these aspects that are important for self-management,
divided into three categories per aspect: 1) capable of
(more) self-management, 2) capable of self-management
with minor barriers, and 3) major barrier(s) for (more)
self-management at this time. These categories were based
on the scoring categories of the original instruments, and
face validity. SeMaS will support the creation of individual
care plans, make it possible to influence barriers for self-
management, and support the referral to and participation
in self-management activities. The profile will provide an
overview of the aspects needing special attention when
undertaking self-management activities.Intervention
The intervention will be delivered at cluster level. The
intervention consists of personalizing self-management
support using the results of the SeMaS questionnaire.The results are represented in a report with a graphic
profile of the patient and tailored advice to enhance self-
management, as described in a manual.Training and support of practice nurses in the
intervention arm
Intervention practice nurses and GPs will receive a two-
hour training session before starting the trial, consisting
of a brief introduction to the SeMaS, demonstration of a
consultation with a SeMaS report and skills practice using
role play. The practice nurses will be specifically instructed
on the options for personalized self-management support,
such as the creation of individual care plans, options
to influence the barriers for self-management, and the
referral to self-management interventions. During the
training, the practice nurses will receive a manual that
indicates which profiles are suitable for self-management,
which are suitable with minor barriers, and which are
unsuitable for self-management at this time. The man-
ual also contains the instructions for personalized self-
management support.
Subsequently, intervention practices will be visited to
provide further support in working with the SeMaS. The
user manual and examples of reports with suggestions for
personalized self-management support will be discussed.Self-management support
During the study period, practice nurses of the intervention
arm will receive a report with the profile of the patients
who filled in the questionnaire. Patients will also receive
tailored feedback. Practice nurses are instructed to adjust
the delivery of care to the profile. For each factor the
manual provides advice to help support the patient in
case of a barrier. For example, when a patient experiences
low social support, the practice nurse and the patient
search for additional social support, or find ways to cope
with this low support. For a patient with low self-efficacy,
the advice is to set a goal with the patient with a high
chance of success, to foster the self-efficacy. When
patients show major barriers for self-management, the
manual gives instruction and support for the practice
nurse to work on this barrier before starting with self-
management activities.
When no barrier is present, the practice nurse is
advised to create an individual care plan with the
patient, and refer to the self-management interventions,
if applicable. Also, the manual contains a card with the
possible self-management interventions, categorized by
the skills that are asked about in the SeMaS questionnaire
(computer, group, self-care). The manual was developed
by the research team and reviewed by the stakeholders
group. The advice was based on the method of actual
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group.
Control practices will deliver care as usual, and will
receive the training one year later. Care as usual may
include the use of an individual care plan or referral to
the self-management interventions, as this is available
for the entire care group. Patients will be invited in the
same inclusion period as in the intervention arm. They
will be asked to fill in the questionnaire, without feedback
to themselves or their practice nurse.Outcomes
The primary outcome is the difference in patient acti-
vation score between baseline and six months between
the intervention and control arm, using the PAM-13
[23]. The PAM-13 is an interval-level, uni-dimensional,
Guttman-like measure. In the study of Greene and
Hibbard the average PAM score was 66.4 (SD 15.4; n =
25,047) [34].
We expect that using the SeMaS instrument will lead
to more effective self-management support. Also, we
expect that patients will adhere better to the self-
management interventions, as they are referred based
on the SeMaS profile. To measure whether the self-
management support is more successful in the inter-
vention arm than in the control arm, we will perform
medical-record data analysis. The outcome measures
include the number of completed individual care plans,
the number of patients performing self-monitoring, the
number of referrals to self-management interventions
(group courses and internet coaches), and adherence to
these interventions, the number of referrals to informative
websites, and the number of consultations in the general
practice and emergency care in the study period. We will
assess how these data relate to the results on the SeMaS
questionnaire at baseline.
Furthermore, we expect that patients who receive
personalized self-management support, will be more
able to improve their lifestyle than patients receiving
care as usual. Lifestyle factors will be measured with
the rapid assessment of physical activity (RAPA) and
the rapid eating assessment for participants-short (REAP-
S) [35,36]. Smoking behavior will be measured with the
10-item Behavior Change Consortium questionnaire [37].
The difference in the score per lifestyle behavior between
baseline and time (T)1 will be calculated to assess the
change in lifestyle behavior. The secondary outcome
measures are defined as the difference in the average
score between control and intervention at T0 and T1
for the RAPA and REAP-S questionnaires. For smoking,
the outcome is defined as the difference between the num-
bers of patients smoking in the control and intervention
arms at T0 and T1.Outcomes from the evaluation questionnaire one week
after consultation
To evaluate whether the SeMaS was discussed, and
which actions were undertaken with the patient, an
evaluation questionnaire was newly developed. Patients
will be asked whether the SeMaS profile was discussed
and which of the psychosocial aspects from SeMaS were
covered during the consultation. Current self-management
activities, and details of whether the patient received
information, advice or referral to interventions for lifestyle
or self-care, will also be covered in the questionnaire. The
participating patients will receive the questionnaire one
week after the consultation. These data will be compared
in the intervention and control arm.
By triangulation of the data from the medical records,
the evaluation questionnaire and the SeMaS profile, we
will assess the number and type of SeMaS dimensions
discussed with the patients related to the SeMaS scores on
these various dimensions. More explicitly, per dimension
we will assess whether this was a barrier in the profile, and
whether it is mentioned in the medical record and the
evaluative questionnaire. If so, this will be scored as proof
of attention. We will assess the percentage of patients with
a barrier and proof of attention for that dimension/barrier.
Qualitative outcomes
The use of SeMaS will be evaluated with the professionals
in the intervention arm by semi-structured interviews.
Informed consent for these interviews will be obtained.
Questions for the interview will be formulated using the
barriers and facilitators on different levels of healthcare
[38]. Special attention will be paid to the usefulness of the
instrument in actual practice and the additional value
for improvement of self-management of patients and the
creation of individual care plans. The purposive sample
size will be determined based on theoretical saturation.
Therefore, data review and analysis will be done in
conjunction with data collection.
Sample size
Sample size calculations have been made using the
results from three studies on the primary outcome
measure, PAM-13 [17,34,39]. In these studies, improve-
ments in PAM scores after intervention vary from 4% to
8% (SD 12 to 17). Based on these studies, we expect to
find a difference in PAM score of 6% (SD 14.0) in this
study. For the power calculations, we assume an intraclass
correlation coefficient (ICC) of 0.05 based on the article of
Campbell et al. [40]. This article states that an ICC of 0.0
to 0.5 is normal for outcomes in primary care research. To
reach a power of 80% and alpha of 0.05, and considering
ICC of 0.05, at least 25 patients per practice are needed
when using 15 practices. With an expected dropout rate
of 33%, 33 patients would be needed per practice, thus,
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measures that will not be applicable to every patient, such
as smoking. Therefore, we strive to include 50 patients per
practice. Thus, 750 patients will be included in total.
Analysis
We made an a priori analysis plan for the primary analysis
of the data, including details about the primary and
secondary outcomes, covariates, treatment of missing
values, and planned analyses. The outline of the analysis
plan will be described here. The primary analysis will be
an intention-to-treat analysis to test the hypothesis that
patients who received personalized self-management
support will be more activated than patients who did not
receive personalized self-management support, expressed
by the PAM-13 score. Secondary analyses will test the
hypothesis that patients who received personalized self-
management support will be more able to change their
lifestyle in a positive way than patients who did not receive
personalized self-management support, as measured
with the RAPA, REAP-S and 10-item Behavior Change
Consortium questionnaire.
Using analysis of covariance (ANCOVA) (that is, multi-
level linear regression with the follow-up score as the
outcome and the baseline score as a covariate), the dif-
ference in scores on PAM-13 in the subgroups at T = 0
and T = 6 months will be examined in the control and
intervention arm. Subsequently, we will analyze the impact
of the intervention on predefined subgroups as measured
by the SeMaS. We defined three subgroups: patients who
are ready for self-management, patients who can undertake
self-management with minor barriers, and patients with
severe barriers to self-management, by calculating an
overall score on the SeMaS questionnaire.
Each secondary outcome will be analyzed with a multi-
level multivariate covariance regression model, with the
analyst blind to practice allocation to trial arms. Covariates
that will be controlled for are: age, gender, chronic
condition (from the medical-record data), social support
(as measured with the SeMaS), diagnosis of depression
based on the International Classification of Primary Care
(ICPC) code and health literacy (as measured with the
Short Test of Functional Health Literacy in Adults (S-
TOFHLA)) [41,42], and the baseline scores. All statistical
analyses will be performed using SPSS software (version
20, IBM Corp.), SAS (version 9.2, SAS Institute Inc.) or
MLWIN (version 2.28, University of Bristol).
We will also perform a per protocol analysis of data from
patients who received a referral to a self-management
intervention. We will examine adherence to the self-
management intervention program, comparing patients
from intervention practices with control. Also, we will
test the effect of the intervention on process outcomes
(filled in individual care plans, the number of referralsto self-management interventions, and the number of
consultations in the general practice and emergency care)
using multilevel multivariate regression techniques.
The effect of cluster will be determined by performing
a multilevel regression analysis without explaining vari-
ables. With this analysis, we can determine the variance
at the different levels. Subsequently, we can determine
the intraclass correlation of this study:
ICC ¼ Clustervariance= Clustervarianceþ Patients0 varianceð Þ
We will qualitatively analyze the interviews with health-
care professionals. The interviews will be transcribed
verbatim. The transcripts will be analyzed by open coding
at macro level using predefined main codes according to
the barriers and facilitators at different levels of healthcare,
as proposed by Grol and Wensing [38]. These levels are:
innovation, individual professional, patient, social context,
organizational structure, and economical and political
context. After the open coding, the research team will
group themes and subthemes for each level of healthcare.
The program Atlas.ti (version 6, ATLAS.ti Scientific
Software Development GmbH) will be used for analysis.
Discussion
This manuscript presents the protocol for a cluster ran-
domized clinical trial of personalized self-management
support, using the SeMaS questionnaire in patients with
chronic conditions, in primary care. By carrying out this
study, scientific evidence is built for the effectiveness
of personalized self-management support. As stated by
Hibbard et al., patient activation is a significant predictor
of healthcare costs [43]. Therefore, if effects of the person-
alized self-management support on the PAM-13 scores
are found, this will also indicate effects on costs.
Limitations of this study
This study is carried out in the DOH care group. This
care group consists of group practices in primary care, and
has an innovative mindset. Therefore, the implementation
of SeMaS in other general practices will need guidance
from experts. Also, implementation in other practices will
need to be evaluated. Recruitment bias may be caused by
the response of patients with certain characteristics, includ-
ing current self-management status, and health literacy.
Due to privacy legislation, it will not be possible to analyze
the characteristics of non-responders.
Trial status
At the time of submission of this study protocol, we are
recruiting patients for the trial.
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